tradingkey.logo
搜索

Nuwellis Inc

NUWE
添加自选
3.150USD
+0.010+0.32%
收盘 07/02, 13:00美东报价延迟15分钟
8.30M总市值
2.31市盈率 TTM

Nuwellis Inc

3.150
+0.010+0.32%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+0.32%

5天

-4.55%

1月

+630.86%

6月

+74.03%

今年开始到现在

+81.03%

1年

-61.79%

关键数据
3.150今开
3.400最高
181.05K成交量
2.31市盈率 TTM
亏损市盈率动
--股息TTM
6.87%换手率
3.140昨收
3.050最低
425.78K成交额
亏损市盈率静
3.12市净率
0.00%股息率 TTM
-272.76%ROA
40.07352周最高
0.81量比
-10.62M净利润
2.64M总股本
1.3622每股收益TTM
0.22Beta
-610.42%ROE
0.72852周最低
11.15%振幅
70.08%毛利率
8.30M总市值
96.91回报/风险
6.49%风险率

TradingKey Nuwellis Inc股票评分

单位: USD 更新时间: 2026-07-02

操作建议

Nuwellis Inc当前公司基本面数据相对健康,增长潜力较大。当前估值合理,在医疗设备与耗材行业排名155/204位。机构持股占比非常高,近一月多位分析师给出公司评级为持有。最高目标价11.00。中期看,股价处于上升通道。近一个月,市场表现很强,技术面评分较高,但很强的走势得没有得到基本面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Nuwellis Inc评分

相关信息

行业排名
155 / 204
全市场排名
448 / 4565
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
极度看空

Nuwellis Inc亮点

亮点风险
Nuwellis, Inc. is a commercial-stage medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
业绩增长期
公司处于发展阶段,最新年度总收入8.27M美元
估值高估
公司最新PE估值2.31,处于3年历史高位
机构加仓
最新机构持股135.71K股,环比增加30.29%
活跃度增加
近期活跃度增加,过去20天平均换手率6.48

分析师目标

根据 1 位分析师
持有
评级
11.000
目标均价
+4890.93%
涨幅空间

Nuwellis Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Nuwellis Inc简介

Nuwellis, Inc. is a commercial-stage medical technology company. The Company is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
公司代码NUWE
公司Nuwellis Inc
CEOErb (John L)
网址https://www.nuwellis.com/

常见问题

Nuwellis Inc(NUWE)的当前股价是多少?

Nuwellis Inc(NUWE)的当前股价是 3.15。

Nuwellis Inc的股票代码是什么?

Nuwellis Inc的股票代码是NUWE。

Nuwellis Inc股票的52周最高点是多少?

Nuwellis Inc股票的52周最高点是40.07。

Nuwellis Inc股票的52周最低点是多少?

Nuwellis Inc股票的52周最低点是0.73。

Nuwellis Inc的市值是多少?

Nuwellis Inc的市值是8.30M。

现在Nuwellis Inc(NUWE)的股票是买入、持有还是卖出?

根据分析师评级,Nuwellis Inc(NUWE)的总体评级为signal_hold,目标价格为11.00。

Nuwellis Inc(NUWE)股票的每股收益(EPS TTM)是多少

Nuwellis Inc(NUWE)股票的每股收益(EPS TTM)是-25.38。